WAM
NEOS

Weiss Asset Management’s Neos Therapeutics, Inc NEOS Stock Holding History

Weiss Asset Management’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-27,600
Closed -$36K – 469
2019
Q2 		$36K Buy
+27,600
New +$50.8K ﹤0.01% 333

Other funds holding NEOS

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Weiss Asset Management's NEOS Position: Q3 2019 in Review

Weiss Asset Management sold out of Neos Therapeutics, Inc (NEOS) in Q3 2019, closing a stake of 27,600 shares — an estimated $36K sold.

Weiss Asset Management first reported a position in NEOS in Q2 2019 and held it in 1 quarter. The position peaked at $36K in Q2 2019. 51 funds tracked by Wall St. Rank hold NEOS as of Q3 2019.

  • Weiss Asset Management reported no remaining Neos Therapeutics, Inc position as of Q3 2019 after selling out during the quarter.
  • Weiss Asset Management sold 27,600 Neos Therapeutics, Inc shares in Q3 2019, an estimated $36K.
  • Weiss Asset Management first reported a position in Neos Therapeutics, Inc in Q2 2019 and held it in 1 quarter.
  • Weiss Asset Management's Neos Therapeutics, Inc position peaked at $36K in Q2 2019.
  • 51 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q3 2019.

Based on Weiss Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.